By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vectura Group plc 

1 Prospect West

Chippenham  Wiltshire  SN14 6FH  United Kingdom
Phone: 44-0-1249-667700 Fax: 44-0-1249-667701



Company News
Vectura (VEC.L) : Mundipharma Presents Positive Findings At ERS 2017 9/12/2017 9:15:40 AM
Vectura (VEC.L) 2017 Interim Results 9/6/2017 10:57:21 AM
Pulmatrix (PULM) Licenses Inhaled COPD Drug PUR0200 To Vectura (VEC.L) 9/6/2017 6:59:57 AM
Vectura (VEC.L) Release: Hikma (HIK.L) Interim Results Statement On Its ANDA For Generic Advair Diskus (VR315) 8/17/2017 7:32:22 AM
Vectura (VEC.L) Release: Board Change 3/6/2017 10:26:12 AM
Vectura (VEC.L) Release: Board Change 3/6/2017 10:13:13 AM
Vectura (VEC.L) Achieves £9 Million Royalty Cap From GlaxoSmithKline (GSK) Ellipta Products 2/16/2017 9:08:54 AM
Vectura (VEC.L) Release: Seebri / Ultibro Breezhaler 2016 Sales Reach $512 Million Triggering $5 Million Milestone Receipt 1/25/2017 10:49:55 AM
Vectura (VEC.L) Release: FDA Approves IND To Support Company’s Wholly-Owned Programme VR647 In Paediatric Asthma 1/24/2017 10:23:55 AM
Vectura (VEC.L) Release: New Findings Confirm Ultibro Breezhaler Consistently More Effective Than Seretide In Reducing COPD Flare-Ups Across Different Patient Groups 9/6/2016 10:38:58 AM